Schrödinger, Inc. has announced a research collaboration and license agreement with Novartis. The agreement includes advancing multiple development candidates into Novartis’s portfolio and an expanded three-year software agreement, which substantially increases Novartis's access to Schrödinger’s computational predictive modeling technology and enterprise informatics platform.